Provident Healthcare Partners Guides Acentus in Its Strategic Acquisition by Henry Schein

On January 16, 2025, Provident Healthcare Partners, a prominent player in healthcare investment banking, announced its advisory role in the acquisition of Acentus by Henry Schein, Inc. This merger marks a significant step in the healthcare industry, particularly for Acentus, a national medical supplier specialized in Continuous Glucose Monitors (CGMs).

Founded in 2018 through the merger of Ally Medical Services and Preston Wound Care, Acentus has carved out a niche in supplying CGMs specifically designed for Medicare patients. The company, headquartered in Tampa, Florida, has seen remarkable growth due to its commitment to integrating advanced technology with exceptional customer service, ensuring that patients and healthcare providers receive affordable and reliable CGM solutions.

The acquisition agreement, which was disclosed on November 20, 2024, will see the founders of Acentus—Brett Carroll, Todd Cianfrocca, Greg Duvall, and Julio Valdivia—join the Henry Schein family. Their experience and knowledge in the healthcare sector are expected to contribute significantly to Henry Schein’s specialized offerings. Todd Cianfrocca, the CEO of Acentus, expressed gratitude towards Provident, praising their “unmatched expertise, experience, and dedication” throughout the acquisition process.

Kevin Palamara, Managing Director at Provident, led the advisory team, highlighting the firm's role in facilitating this strategic transaction. Meanwhile, legal support for Acentus was provided by Robinson Cole. Brendan Schroeder, a Senior Associate at Provident, echoed Cianfrocca’s sentiments on the importance of Acentus’ innovative CGM platform which has achieved considerable market traction since its launch.

Henry Schein, known for providing tailored solutions in the healthcare sector, is expected to leverage Acentus' established products to enhance its portfolio while serving over a million customers globally. The company operates under more than 300 solutions designed to improve clinical outcomes and operational success. Headquartered in Melville, New York, Henry Schein is a FORTUNE 500 company with a wide-reaching global footprint across 33 countries.

The successful integration of Acentus into Henry Schein is anticipated to further strengthen the supply of CGMs, particularly as the demand for these vital medical devices continues to grow. With the increasing awareness of diabetes management, this merger positions both companies favorably in the evolving healthcare landscape.

As this partnership unfolds, the potential for enhanced innovation and service offerings in the realm of diabetes care seems promising. The collaboration represents a step towards improved patient outcomes through innovative healthcare solutions, further establishing both Acentus and Henry Schein as leaders in the medical supply industry.

Provident Healthcare Partners' well-established reputation in merger and acquisition advisory roles demonstrates their effectiveness in navigating complex healthcare transactions. Their profound understanding of the durable medical equipment sector, combined with a vast network of investors, equips them to support clients in achieving their strategic objectives seamlessly.

For more information on Acentus and its offerings, visit www.acentus365.com. To learn more about Henry Schein’s services, check out www.henryschein.com. Additionally, for insight on Provident Healthcare Partners, their work, and their expertise, you can explore their official site at www.providenthp.com.